|
|
||||||||
1 From the Graduate Program in Neuroscience and the 2 Departments of Ophthalmology and 3 Neuropathology, University of Virginia Health Sciences Center, Charlottesville, Virginia.
PURPOSE. Interphotoreceptor retinoid-binding protein (IRBP), which is secreted
by the photoreceptors of most vertebrates, is the major soluble protein
component of the interphotoreceptor matrix (IPM). Recent studies
suggest that IRBP is short lived in the IPM (half-life,
11 hours).
The mechanisms coordinating the production and removal of IRBP are not
known. Zebrafish provide a useful system to study the regulation of
these two processes, because its IRBP mRNA levels are under circadian
regulation. In the present study, the relationship between the quantity
of IRBP, the rate of its turnover, and the expression of its mRNA in
the zebrafish retina were examined.
METHODS. Full-length zebrafish IRBP was expressed in Escherichia coli and an antiserum generated against purified recombinant IRBP. Western and protein dot blot analyses and indirect immunofluorescence were used to define the temporal and spatial patterns of IRBP expression in the adult zebrafish. In vivo and in vitro metabolic labeling experiments were used to examine the regulation of IRBP turnover by both environmental light and the lightdark cycle.
RESULTS. Despite the known rhythmicity in IRBP mRNA expression, neither the
amount of IRBP nor its localization changes significantly during the
lightdark cycle. IRBP is rapidly removed from the zebrafish eye (half
life,
7 hours). This rapid turnover is independent of environmental
lighting conditions during subjective day and is more rapid during the
day than at night.
CONCLUSIONS. Because the amount of IRBP remains constant throughout the day, the enhanced daytime IRBP mRNA expression may function to compensate for an increased turnover of the protein during the day. These findings suggest that the processes of IRBP production and removal are coordinately regulated.
This article has been cited by other articles:
![]() |
V. Krishnamoorthy, V. Jain, P. Cherukuri, S. Baloni, and N. K. Dhingra Intravitreal Injection of Fluorochrome-Conjugated Peanut Agglutinin Results in Specific and Reversible Labeling of Mammalian Cones In Vivo Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2643 - 2650. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |